Comparison Between a 1L of Polyethylene Glycol+Ascorbic Acid as a Split Dose Bowel Preparation for Colonoscopy
NCT ID: NCT04758156
Last Updated: 2021-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
200 participants
INTERVENTIONAL
2019-08-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
study design: prospective, randomized, parallel, multi-center trial in 3 hospitals in Korea ( Seoul National University hospital, Seoul National University Bundang hospital, Seoul Metropolitan Government-Seoul National University )
patient inclusion criteria
\- aged 20-75 adults (out-clinic patients) scheduled for colonoscopy for any indication within the normal process of care
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy
NCT01740518
Effect of Simethicone on Bowel Preparation for Colonoscopy
NCT02548403
A Randomized Prospective Trial Comparing Low-volume Bowel Preparation Methods
NCT02250196
Bowel Preparation for Colonoscopy in the Elderly
NCT02290093
The Comparative Study Between Bowel Preparation Method
NCT01964417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CleanViewAL
1L polyethylene glycol+ascorbic acid split dose
CleanViewAL
1L PEG + ascorbic acid bowel preparation for colonoscopy
SUPREP
Oral sulfate solutiom
SUPREP
Oral sulfate solution for colonoscopy bowel preparation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CleanViewAL
1L PEG + ascorbic acid bowel preparation for colonoscopy
SUPREP
Oral sulfate solution for colonoscopy bowel preparation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* known or clinically suspicious Inflammatory bowel disease patients
* known or suspected ileus/ GI obstruction
* previous history of major cancer or currently on treating cancer
* Major cardiovascular disease, respiratory disease, liver, hematologic diseases with complication
* severe cognitive impairment / dementia / confusion state
* past history within the last 12 months or current episode of severe constipation severe constipation
* Regular use of laxatives or colon motility-altering drugs (i. e. more than 2 - 3 times per week) in the last 28 days prior to screening and/or laxative use within 72 hours prior to administration of the preparation)
* women who are pregnant or lactating
* known phenylketonuria, glucose-6-phosphate dehydrogenase deficiency
* those who were allergic to any preparation components.
* those who, in the opinion of the investigator, should not be included in the study for any reason
20 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyun Jung Lee
Assistant Professor, MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jong Pil Im, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul national university hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1905-1831
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.